Team of scientists in Frankfurt and Kent discover potential contributor to COVID-19 severity

The Institute of Medical Virology at Goethe-University, Frankfurt am Main, Germany, and the University of Kent’s School of Biosciences (UK) have identified that a glycoprotein known as transferrin may critically contribute to severe forms of COVID-19.

SARS-CoV-2 is the coronavirus that causes COVID-19. It is currently not known why some individuals develop only mild or no symptoms when infected, whilst others experience severe, life-threatening forms of the disease. However, it is known that the risk of COVID-19 becoming severe increases with age and is higher in males than in females. Many severe COVID-19 cases are characterised by increased blood clotting and thrombosis formation.

The team combined existing data on gene expression in humans with cell culture research of SARS-CoV-2-infected cells to search for molecules involved in blood coagulation that differ between females and males, change with age, and are regulated in response to SARS-CoV-2 infection.

Out of more than 200 candidate factors, researchers identified a glycoprotein called transferrin to be a procoagulant (a cause of blood clotting) that increases with age, is higher in males than in females, and is higher in SARS-CoV-2-infected cells. Hence, transferrin may have potential as a biomarker for the early identification of COVID-19 patients at high risk of severe disease.

Publication: Katie-May McLaughlin, Marco Bechtel, Denisa Bojkova, Christian Münch, Sandra Ciesek, Mark N. Wass, Martin Michaelis, Jindrich Cinatl, Jr.: COVID-19-Related Coagulopathy – Is Transferrin a Missing Link? Diagnostics 2020, 10(8), 539; https://doi.org/10.3390/diagnostics10080539

Source: Press release from 3 August 2020

Relevante Artikel

Bücher für den Geschenketisch

Kurz vor dem Weihnachtsfest sind sicherlich noch viele auf der Suche nach einem inspirierenden Geschenk, vielleicht sogar mit Bezug zur

Öffentliche Veranstaltungen

You cannot copy content of this page